Vertex Pharmaceuticals has grown from a $7.5 billion market cap to over $120 billion as it’s commercialized several products.

Gene editing technologies have cemented their place as a valued method in the biological toolkit used by researchers around the globe.

In a new development, researchers have successfully created an efficient two-line system for hybrid seed production in ...

RAPID-CRISPR test quickly and accurately diagnoses acute promyelocytic leukemia, a rare and aggressive blood cancer, with ...

Learn about Brink Therapeutics as it raises $4 million to go beyond CRISPR with engineered recombinases in CAR T therapy.

Latest study leverages new constructs for nuclear localization signal (NLS) sequences to improve editing efficiency in human immune cells.

Doctors and researchers at the University of Nebraska Medical Center are hoping to bring a different therapy that uses a ...

CRISPR technology uncovers new key genes and pathways linked to Parkinson’s disease, offering insights into risk and ...

Learn more about whether CRISPR Therapeutics AG or Neurocrine Biosciences, Inc. is a better investment based on AAII's A+ ...

A longstanding mystery in Parkinson's disease research has been why some individuals carrying pathogenic variants that ...